申请人:University of the Sciences in Philadelphia
公开号:US06063790A1
公开(公告)日:2000-05-16
In accordance with the present invention, there is now provided novel anti-HIV compounds of the formulae selected from the group consisting of: ##STR1## wherein R.sub.1 is hydrogen or C.sub.1 -C.sub.4 alkyl; R.sub.2 is hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy or halogen; R.sub.3 is hydrogen, hydroxy, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy or halogen; R.sub.4 is hydrogen or halogen, R.sub.5 is hydrogen; C.sub.1 -C.sub.4 alkoxy, nitro, halogen or haloalkyl; R.sub.6 is hydrogen or nitro; R.sub.7 is hydrogen or C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, nitro or halogen; R.sub.8 is hydrogen, hydroxy, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy or halogen; R.sub.9 is hydrogen or nitro; R.sub.10 is hydrogen or halogen; R.sub.11 is hydrogen, C.sub.1 -C.sub.4 amine; R.sub.12 is hydrogen, C.sub.1 -C.sub.4 alkyl or halogen; R.sub.13 is hydrogen, C.sub.1 -C.sub.4 amine; R.sub.14 is hydrogen or halogen; R.sub.15 is hydrogen, C.sub.1 -C.sub.4 alkoxy, C.sub.1 -C.sub.4 haloalkyl, nitro, or halogen; R.sub.16 is hydrogen or nitro; R.sub.17 is hydrogen, C.sub.1 -C.sub.4 alkyl, C.sub.1 -C.sub.4 alkoxy, nitro or halogen; R.sub.18 is hydrogen, C.sub.1 -C.sub.4 alkoxy, hydroxy, or halogen; R.sub.19 is hydrogen or nitro; and R.sub.20 is hydrogen or halogen and R.sub.21 is hydrogen or NO.sub.2, or a pharmaceutically acceptable salt thereof.
根据本发明,现提供了选择自以下组的式子的新型抗HIV化合物:其中R1为氢或C1-C4烷基;R2为氢、C1-C4烷基、C1-C4烷氧基或卤素;R3为氢、羟基、C1-C4烷基、C1-C4烷氧基或卤素;R4为氢或卤素、R5为氢、C1-C4烷氧基、硝基、卤素或卤代烷基;R6为氢或硝基;R7为氢或C1-C4烷基、C1-C4烷氧基、硝基或卤素;R8为氢、羟基、C1-C4烷基、C1-C4烷氧基或卤素;R9为氢或硝基;R10为氢或卤素;R11为氢、C1-C4胺基;R12为氢、C1-C4烷基或卤素;R13为氢、C1-C4胺基;R14为氢或卤素;R15为氢、C1-C4烷氧基、C1-C4卤代烷基、硝基或卤素;R16为氢或硝基;R17为氢、C1-C4烷基、C1-C4烷氧基、硝基或卤素;R18为氢、C1-C4烷氧基、羟基或卤素;R19为氢或硝基;R20为氢或卤素,R21为氢或NO2,或其药学上可接受的盐。